The National Center for Biotechnology Information has released RefSeq 29.
This release includes genomic, transcript, and protein data available as of May 4, 2008, and includes 8,376,141 records; 5,482,876 proteins; and sequences from 5,168 different organisms.
Ludesi has released version 2.0 of its REDFIN image- and data-management software. The new version allows researchers to share Ludesi-analyzed experiments with distributed colleagues by clicking on a “share” button and entering the email address of the sharing recipient.
Researchers sharing a project are able to grant read-only or read/write access to experiments, and projects can be un-shared at any time.
REDFIN is available here for free. Recipients do not need to be Ludesi customers in order to view shared experiments, the company said.
Biobase has released Cell Illustrator, a software package for visualizing and simulating biological processes. The software allows users to draw biological reactions, model observed processes, and simulate processes.
Cell Illustrator is integrated with Biobase’s Transpath database, giving users the ability to model metabolic pathways, signal transduction cascades, and gene regulatory pathways, the company said.
A free trial of Cell Illustrator is available here.
The Numerical Applications Group has released the NAG Toolbox for Matlab, which provides more than 1,300 math and statistical algorithms within the Matlab environment. “This additional mathematical and statistical functionality was previously unavailable or accessible to MATLAB users only by purchasing multiple toolboxes,” NAG said in a statement.
Pricing for the NAG Toolbox for MATLAB begins at $2,490 for an individual license. It is available for Windows 32-bit and 64-bit and Linux 32-bit and 64-bit and is compatible with Matlab versions 2007a, 2007b, and 2008a.
Iris BioTechnologies has launched BioWindows, a database system that allows patients to compile personal profiles to help determine the most appropriate medical solution based on their individual characteristics. Users enter personal information — including demographics, medical history, and lifestyle choices — into the database, and the BioWindows system uses this data in combination with information from a tissue biopsy “to accurately assess the most optimal form of treatment” by comparing the information to a central repository of gene profiles, the company said.